HomeComparePTRA vs MRK

PTRA vs MRK: Dividend Comparison 2026

PTRA yields 2985.07% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTRA wins by $433539968075.06M in total portfolio value
10 years
PTRA
PTRA
● Live price
2985.07%
Share price
$0.07
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$433539968075.12M
Annual income
$406,736,225,519,142,500.00
Full PTRA calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — PTRA vs MRK

📍 PTRA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTRAMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTRA + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTRA pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTRA
Annual income on $10K today (after 15% tax)
$253,731.34/yr
After 10yr DRIP, annual income (after tax)
$345,725,791,691,271,200.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, PTRA beats the other by $345,725,791,691,262,850.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTRA + MRK for your $10,000?

PTRA: 50%MRK: 50%
100% MRK50/50100% PTRA
Portfolio after 10yr
$216769984037.59M
Annual income
$203,368,112,759,576,160.00/yr
Blended yield
93.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

PTRA
Analyst Ratings
2
Buy
4
Hold
1
Sell
Consensus: Hold
Price Target
$7.00
+10347.8% upside vs current
Range: $7.00 — $7.00
Altman Z
-2.8
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTRA buys
0
MRK buys
0
No recent congressional trades found for PTRA or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTRAMRK
Forward yield2985.07%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$433539968075.12M$56.8K
Annual income after 10y$406,736,225,519,142,500.00$9,798.13
Total dividends collected$431686299125.80M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$7.00$128.54

Year-by-year: PTRA vs MRK ($10,000, DRIP)

YearPTRA PortfolioPTRA Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$309,207$298,507.46$11,206$366.19+$298.0KPTRA
2$8,957,089$8,626,236.93$12,650$502.35+$8.94MPTRA
3$243,120,454$233,536,368.64$14,407$694.19+$243.11MPTRA
4$6,184,279,490$5,924,140,604.30$16,585$967.82+$6184.26MPTRA
5$147,451,722,719$140,834,543,664.57$19,342$1,363.89+$147451.70MPTRA
6$3,296,013,356,428$3,138,240,013,119.13$22,913$1,947.19+$3296013.33MPTRA
7$69,087,118,460,072$65,560,384,168,694.19$27,662$2,823.89+$69087118.43MPTRA
8$1,358,221,282,082,432$1,284,298,065,330,154.50$34,159$4,173.35+$1358221282.05MPTRA
9$25,050,226,687,827,436$23,596,929,915,999,230.00$43,337$6,308.80+$25050226687.78MPTRA
10$433,539,968,075,117,900$406,736,225,519,142,500.00$56,776$9,798.13+$433539968075.06MPTRA

PTRA vs MRK: Complete Analysis 2026

PTRAStock

Proterra Inc. provides commercial vehicles in the United States, the European Union, Canada, Australia, and Japan. It operates through Proterra Powered and Energy and Proterra Transit business units. The Proterra Powered and Energy business unit designs, develops, manufactures, sells, and integrates battery systems and electrification solutions into vehicles for commercial vehicle OEM customers serving delivery trucks, school buses, coach buses, construction and mining equipment, and other applications. It also provides turnkey fleet-scale, high-power charging solutions and software services, ranging from fleet and energy management software-as-a-service to fleet planning, hardware, infrastructure, installation, utility engagement, and charging optimization. The Proterra Transit business unit designs, develops, manufactures, and sells electric transit buses as an OEM for North American public transit agencies, airports, universities, and other commercial transit fleets. Proterra Inc. was incorporated in 2004 and is headquartered in Burlingame, California.

Full PTRA Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this PTRA vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTRA vs SCHDPTRA vs JEPIPTRA vs OPTRA vs KOPTRA vs MAINPTRA vs JNJPTRA vs ABBVPTRA vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.